Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Payables (2016 - 2025)

SRx Health Solutions (SRXH) has disclosed Payables for 15 consecutive years, with $2.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Payables fell 95.07% year-over-year to $2.1 million, compared with a TTM value of $2.1 million through Sep 2025, down 95.07%, and an annual FY2025 reading of $2.1 million, changed N/A over the prior year.
  • Payables was $2.1 million for Q3 2025 at SRx Health Solutions, down from $38.9 million in the prior quarter.
  • Across five years, Payables topped out at $43.6 million in Q3 2024 and bottomed at $100000.0 in Q3 2023.
  • Average Payables over 5 years is $8.0 million, with a median of $4.4 million recorded in 2025.
  • The sharpest move saw Payables tumbled 97.4% in 2023, then skyrocketed 43457.0% in 2024.
  • Year by year, Payables stood at $4.6 million in 2021, then crashed by 35.6% to $2.9 million in 2022, then soared by 136.29% to $6.9 million in 2023, then crashed by 54.72% to $3.1 million in 2024, then tumbled by 31.56% to $2.1 million in 2025.
  • Business Quant data shows Payables for SRXH at $2.1 million in Q3 2025, $38.9 million in Q2 2025, and $4.4 million in Q1 2025.